Results 101 to 110 of about 141,463 (194)

Therapeutic and diagnostic applications of extracellular vesicles [PDF]

, 2016
De Smedt, Stefaan, Raemdonck, Koen, Stremersch, Stephan   +2 more
core   +1 more source

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less

Iranian Journal of Public Health, 2015
Background: We aimed to value the usefulness of free to total prostate-specific antigen and Prostate-specific antigen (PSA) density for prostate cancer in the patients with PSA levels of 4.0 ng/ml or less.
Xin LIU, Jie TANG, Xiang FEI, Qiu-Yang LI   +3 more
doaj  

Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? [PDF]

Eur Urol Focus, 2023
Pellegrino F, Tin AL, Martini A, Vertosick EA, Porwal SP, Stabile A, Gandaglia G, Eastham JA, Briganti A, Montorsi F, Vickers AJ.   +10 more
europepmc   +1 more source

Letter to the Editor. Re: single potential analysis of cavernous electrical activity in spinal cord injury patients. [PDF]

, 1994
Höppner, C., Jonas, Udo, Noack, T., Sauerwein, D., Stief, Christian Georg   +4 more
core   +1 more source

The role of prostate-specific antigen density and negative multiparametric magnetic resonance imaging in excluding prostate cancer for biopsy-naïve men: clinical outcomes from a high-volume center in China. [PDF]

Asian J Androl, 2022
Zhang CC, Tu X, Lin TH, Cai DM, Yang L, Nie L, Qiu S, Liu ZH, Jin K, Li JK, Xiong XY, Yang L, Wei Q.   +12 more
europepmc   +1 more source

Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy. [PDF]

J Clin Med, 2023
Huang C, He S, He Q, Gong Y, Song G, Zhou L.   +5 more
europepmc   +1 more source

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study. [PDF]

Front Oncol, 2022
Lei Y, Li TJ, Gu P, Yang YK, Zhao L, Gao C, Hu J, Liu XD.   +7 more
europepmc   +1 more source

Diagnostic Value of Transabdominal Ultrasound-based Versus Magnetic Resonance Imaging-based Prostate-specific Antigen Density for Clinically Significant Prostate Cancer. [PDF]

Eur Urol Open Sci
Xu Z, Song H, Huang H, Fu M, Tang Y, Zhang P, Zhang G, Li J.   +7 more
europepmc   +1 more source

Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate-specific antigen, digital rectal examination and the prostate-specific antigen density based on digital rectal prostate volume category. [PDF]

BJUI Compass, 2023
Morote J, Triquell M, Campistol M, Abascal JM, Servian P, Trilla E.   +5 more
europepmc   +1 more source

Diagnostic accuracy of prostate-specific antigen and prostate-specific antigen density in patients suspected of having prostate cancer in South Korea: A large, multi-institutional registry. [PDF]

Investig Clin Urol
Yun JE, Lee KS, Lee H, Lee SH, Jung JH, Hwang EC, Lee NR, Han WK, Yu SY.   +8 more
europepmc   +1 more source